Article

ARVO chooses innovation as theme for annual gathering

More than 10,000 vision researchers, practitioners, and others from around the world are expected to journey to the Association for Research in Vision and Ophthalmology's 80th annual meeting, set for Sunday, April 27, to Thursday, May 1, in Fort Lauderdale, FL. Attendees will explore the latest techniques, protocols, and tools in development and use by ophthalmic researchers through education courses, lectures, poster and paper presentations, special-interest group and general business gatherings, mini-symposia and symposia, and workshops.

Fort Lauderdale, FL-"Eyes on Innovation" is the theme for the 2008 Association for Research in Vision and Ophthalmology (ARVO) 80th annual meeting, set here for Sunday, April 27, to Thursday, May 1.

This meeting always offers a chance for vision researchers and practitioners to explore the latest techniques, protocols, and tools in development and use by ophthalmic researchers. More than 10,000 professionals from around the world are expected to journey to this annual rite of spring.

Kurzweil was the principal developer of the first charge-coupled device flat-bed scanner, the first omni-font optical character recognition technology, the first print-to-speech reading machine for the blind, the first text-to-speech synthesizer, the first music synthesizer capable of recreating the grand piano and other orchestral instruments, and the first commercially marketed large-vocabulary speech recognition equipment.

Among Kurzweil's many honors is the Lemelson-MIT Prize, a prestigious award for innovation. Also, in 1999, he received the National Medal of Technology, the nation's highest honor in technology, from President Bill Clinton.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.